Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone to prolong adductor canal block after total knee arthroplasty
ACTRN12614000982617Phase 2Not yet recruiting
- Sponsor
- Fremantle Hospital
- Start
- Sep 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone and ropivacaine in postoperative pain (3 arms), sponsored by Fremantle Hospital. Primary endpoint: Duration of sensory block. Planned start Sep 2014; status: not yet recruiting.
02
Drugs
dexamethasoneropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12614000982617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000982617.